• Grant Hovik, MA, Clinical Specialist, UCLA Integrated Substance Abuse Programs, Pacific Southwest Addiction Technology Transfer Center (HHS Region 9)
• Andrew S. Kurtz, MA, MFT, Clinical Specialist, UCLA Integrated Substance Abuse Programs, Pacific Southwest Addiction Technology Transfer Center (HHS Region 9)
• David Hindman, Ph.D., Chief, Clinical Standards and Training Unit Substance Abuse Prevention & Control
• Brandon Fernandez, MPH, Chief Operating Officer, Cri-Help, Inc.
• Irene Lim, LCSW, Program Manager, Substance Use Prevention & Treatment Program, Division of Adolescent & Young Adult Medicine Children’s Hospital Los Angeles

This Lecture Series presentation will describe the local and national scope of Stimulant Use Disorders including current trends in use amongst special populations (e.g., adolescents, women, criminal justice populations, racial/ethnic minorities, and LGBT individuals). The mental health and physical health consequences of Stimulant Use Disorders will be presented including information on stimulant use and its impact on the brain and cognition. The presentation will

conclude with a discussion on how to implement effective treatment interventions to people who use stimulants and the necessary adaptations needed to engage and retain special populations in care. Effective behavioral treatments for stimulant use tailored to stage of treatment will be discussed.

A panel discussion will follow this presentation, featuring representatives from SAPCs specialty substance use disorder (SUD) treatment provider network, with particular experience or focus on treatment of Stimulant Use Disorders. This portion of the presentation is intended to assist SUD providers in identifying and addressing real world considerations in effectively engaging patients in care, making level of care determinations for Stimulant Use Disorders and

practical treatment and programmatic approaches to treatment. Additionally, panelists will share their perspectives on the growing use on varying stimulants, as well as their efforts to implement evidence-based treatment options to assist in addressing this ongoing and increasingly growing epidemic.